Jeff Rosenbloom

Jeff Rosenbloom is an accomplished professional in the biotechnology field, currently serving as the Director of MSAT at Capricor Therapeutics, Inc. since November 2024. Previously, Jeff held the position of Director of MSAT for Cell and Gene Therapy at AGC Biologics, where leadership resulted in a 50% reduction in technology transfer timelines through process optimization and strategic resource allocation. Prior to that, Jeff managed the Cell Therapy MSAT Scientist team at Lonza, focusing on the technology transfer of new clinical and commercial programs to GMP Manufacturing. Jeff's extensive experience includes roles as Principal Scientist and Senior Scientist at Intrexon Corporation, where key responsibilities included budget management, project deliverables, and leading complex scientific programs. Jeff began a career in bioprocessing at GT Life Sciences, contributing to advancements in cell growth and productivity. Academic credentials include a Masters of BioScience in Bioprocessing and Business of Bioscience from Keck Graduate Institute and a Bachelor of Science in Integrated Biology from the University of Florida.